Literature DB >> 22974742

Pharmaceuticals in the environment: lessons learned for reducing uncertainties in environmental risk assessment.

Bryan W Brooks1, Jason P Berninger, Lauren A Kristofco, Alejandro J Ramirez, Jacob K Stanley, Theodore W Valenti.   

Abstract

Pharmaceuticals in the environment are often present at trace levels (e.g., ng/L) in surface waters and effluents of developed countries, yet represent contaminants of emerging concern. Attributes of many of these substances, such as potency, chirality, and ionization, present challenges to historical environmental risk assessment and management paradigms. In this chapter, we critically examine several important aspects of pharmaceuticals, specifically highlighting some of the lessons we have learned from studying these substances in the environment over the past 15 years. We submit that incorporating such "lessons learned" during environmental risk assessments promises to reduce uncertainties and support more sustainable management efforts.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22974742     DOI: 10.1016/B978-0-12-415813-9.00008-8

Source DB:  PubMed          Journal:  Prog Mol Biol Transl Sci        ISSN: 1877-1173            Impact factor:   3.622


  2 in total

Review 1.  Ethinyl estradiol and other human pharmaceutical estrogens in the aquatic environment: a review of recent risk assessment data.

Authors:  James P Laurenson; Raanan A Bloom; Stephen Page; Nakissa Sadrieh
Journal:  AAPS J       Date:  2014-01-28       Impact factor: 4.009

2.  Urbanization, environment and pharmaceuticals: advancing comparative physiology, pharmacology and toxicology.

Authors:  Bryan W Brooks
Journal:  Conserv Physiol       Date:  2018-01-17       Impact factor: 3.079

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.